A promising treatment option for refractory male primary choriocarcinoma: report of two cases

Male primary choriocarcinoma is a rare and invasive malignant neoplasm for which traditional chemotherapy has limited efficacy. Pembrolizumab is a humanized monoclonal anti-programmed death-1 antibody that has antitumor activity in numerous malignancies. The diagnosis and treatment of two cases of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Chen, Zhou, Ying, Ma, Jin-An, Liu, Jia, Jiang, Yu-Na, Zhang, Hai-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799262/
https://www.ncbi.nlm.nih.gov/pubmed/35117666
http://dx.doi.org/10.21037/tcr.2020.02.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799262/
https://www.ncbi.nlm.nih.gov/pubmed/35117666
http://dx.doi.org/10.21037/tcr.2020.02.05

Ejemplares similares